Smith-Lemli-Opitz Syndrome

Smith-Lemli-Opitz Syndrome is a rare genetic condition. It affects how the body makes cholesterol. This leads to problems with brain development, physical growth, and the formation of organs. People with this syndrome often have unique physical features and may face challenges with learning and development.

Condition

What people with Smith-Lemli-Opitz Syndrome report

Every report comes from a Lived member, sent anonymously.

Have you had Gastrostomy for Smith-Lemli-Opitz Syndrome?

NameHow it went

About Smith-Lemli-Opitz Syndrome

What It Is

Smith-Lemli-Opitz syndrome (SLOS) is an inherited condition in which the body cannot finish making its own cholesterol. Cholesterol is often thought of only as a heart-health number, but the body needs it to build cell membranes, the insulation around nerve cells and several hormones, especially while a baby is developing before birth. In SLOS, too little cholesterol is made and a building block called 7-dehydrocholesterol (7-DHC) piles up instead. Together, these changes disrupt how many parts of the body form and grow. The condition is usually present from birth. Common features include a small head size, distinctive facial features, fused second and third toes, weak muscle tone in infancy, feeding difficulties, slow growth, and intellectual disability or learning problems. Many children have autistic traits, sleep problems and sensitivity to sunlight. Some are born with differences in the heart, kidneys, digestive tract or genitals, or with a cleft palate or extra fingers or toes. Severity varies more than the name suggests. At one end, babies have major malformations and may not survive the newborn period. At the other, people have only minor physical differences along with learning and behavior challenges, and a few have developed normally.

Causes & Risk Factors

SLOS is caused by changes in both copies of a gene called DHCR7, which carries the instructions for the enzyme that performs the last step of cholesterol production. It is not caused by anything a parent did during pregnancy, and a child's diet does not cause it. The condition is inherited in an autosomal recessive pattern. Each parent of an affected child usually carries one changed copy of the gene and is healthy. When both parents are carriers, each pregnancy has a 25% (one in four) chance of a child with SLOS, a 50% chance of a child who is a healthy carrier, and a 25% chance of a child who neither has the condition nor carries it. SLOS is estimated to affect about 1 in 20,000 to 60,000 newborns and is most common in people of Central European ancestry.

How It's Diagnosed

Most children are recognized at birth or in infancy, when a combination of features such as fused toes, a cleft palate, feeding problems and slow growth prompts testing. The key test measures 7-DHC in the blood. A high level points strongly to SLOS, and genetic testing that finds changes in both copies of DHCR7 confirms it. A routine cholesterol test can be misleading. Cholesterol is usually low, but in about one in ten affected people it falls in the normal range, partly because standard lab methods can count 7-DHC as cholesterol. A normal cholesterol result therefore does not rule SLOS out. Certain psychiatric medicines, including aripiprazole and trazodone, can also raise 7-DHC in people without SLOS, which is one reason genetic testing is used to settle unclear results. SLOS can sometimes be suspected before birth. An unusually low level of a hormone called unconjugated estriol on second-trimester screening, or slow growth and malformations on ultrasound, can lead to testing of amniotic fluid or placental tissue for 7-DHC. Families with an affected child can arrange carrier and prenatal testing once the family's gene changes are known.

Treatment Options

There is no cure for SLOS. Treatment aims to support growth, development, comfort and safety, and is usually coordinated by a genetics or metabolic specialist alongside other specialists. Most people take extra cholesterol by mouth, either from foods such as egg yolks or as a specially prepared cholesterol supplement. This raises blood cholesterol and can lower 7-DHC production. Reports describe improvements in growth, infections, behavior and sun sensitivity, but the evidence comes mainly from small case series, and a blinded study found no short-term change in behavior compared with placebo. Cholesterol taken by mouth also does not reach the brain in any meaningful amount, which limits what it can do for learning and development. Statins (cholesterol-lowering drugs that also reduce 7-DHC production) have been tried as an add-on, but a 2022 review found too little evidence that they help and a possible increase in side effects. Much of the day-to-day benefit comes from supportive care. Feeding therapy, nutritional support and often a feeding tube placed in the stomach (gastrostomy) help infants who cannot take in enough by mouth. Early intervention with physical, occupational and speech therapy supports development, and sign language or picture and device-based communication can help children who speak little. Surgery may repair a cleft palate, heart defect, extra digits, genital differences or digestive blockages, and orthotics or treatment for tight muscles may help mobility. Sleep problems and behavior concerns are treated individually. Two medical points matter for choosing treatments. The antipsychotic haloperidol, the antidepressant trazodone and the antipsychotic aripiprazole raise 7-DHC and are generally avoided or used only with close monitoring, so any clinician prescribing for anxiety, sleep or behavior should know about the diagnosis. Some severely affected people also have adrenal insufficiency (low output of the stress hormone cortisol) and need extra steroid doses during illness, surgery or other physical stress.

What to Expect

The course depends heavily on severity. Infancy is often the hardest period, with poor feeding, reflux, constipation, irritability and slow weight gain. Because growth does not respond normally to extra calories, the usual goal is steady weight gain rather than catching up to standard growth charts, and SLOS-specific growth charts are used alongside them. Weak muscle tone often gives way to tight muscles later in childhood. Most children have mild to moderate intellectual disability, though some have borderline or normal intelligence. Autistic traits, sensory sensitivities, sleep disruption, anxiety and, in some, self-injury can shape family life as much as the physical features. Sensitivity to sunlight is common, so protective clothing, a broad-spectrum sunscreen and limiting long sun exposure become part of the routine. Regular follow-up tracks growth, nutrition, development, behavior, vision, hearing and teeth, and blood tests check cholesterol, 7-DHC and liver function, often every few months in early childhood and less often later. Adults with SLOS tend to be shorter than average, and depression and anxiety are common. Many people with milder forms reach adulthood, but there is little long-term data on adult health and life expectancy.

When to Seek Help

Ask for an evaluation, and possibly referral to a genetics specialist, when a baby or child has several features suggestive of SLOS, such as fused second and third toes with feeding problems, slow growth or developmental delay, or when a family member has SLOS and you are planning a pregnancy. For someone already diagnosed, contact the care team promptly about poor feeding, repeated vomiting or weight loss, new seizures, or a marked change in behavior or sleep. If the person has adrenal insufficiency, call the care team as soon as they become ill or need surgery so that steroid doses can be adjusted under the plan you have agreed with them. Tell any new prescriber about the diagnosis before starting a medicine for mood, behavior or sleep.

Questions to Ask Your Doctor

  1. 1.Where on the spectrum of SLOS does this appear to fall, and what does that suggest for growth and development?
  2. 2.What do you expect cholesterol supplementation to achieve, and how will we judge whether it is helping?
  3. 3.Which specialists and therapies should be part of care now, and which can wait?
  4. 4.Is there any sign of adrenal insufficiency, and do we need a plan for illness or surgery?
  5. 5.What are the chances of SLOS in a future pregnancy, and what testing is available for relatives?

Last reviewed • Oct 2026

Educational content, not medical advice.